Topic resource collection
Approved comparison material connected to this topic.
4 resourcesRead both sides
Both BPC-157 and TB-500 appear in plantar fasciitis protocols, but they activate different cellular pathways. BPC-157 primarily stimulates VEGF (vascular endothelial growth factor) release and nitric oxide synthase activity. Mean…
BPC-157 VEGF upregulation, fibroblast migration, angiogenesis at injury site 250–500 mcg SC twice daily 4–6 weeks (collagen density) Moderate (indirectly through vascularization) Best for acute injuries and microtear repair. Addr…
BPC-157 VEGFR-2 upregulation drives angiogenesis; fibroblast migration acceleration 200–500 mcg daily SC, near injury site Animal models + case reports; no RCTs Requires daily dosing; local administration preferred TB-500 Actin p…
BPC-157 Upregulates VEGF and FGF to increase capillary density; modulates TGF-β1 to reduce inflammatory cytokines Daily (250–500 mcg) Localized. Within 2–3 cm of plantar fascia Accelerates collagen synthesis and tensile strength …